Native American Church

FRC's Andrew Brunson Unveils New Video Series on Potential Domestic Religious Persecution in the Wake of the Impending Dobbs Decision

Retrieved on: 
Tuesday, June 14, 2022

The video series is being distributed to tens of thousands of pastors and other church leaders that comprise FRC's Association of Churches and Ministries.

Key Points: 
  • The video series is being distributed to tens of thousands of pastors and other church leaders that comprise FRC's Association of Churches and Ministries.
  • In October 2016, Andrew Brunson was falsely accused on terrorism charges, and was held for two years in Turkish prisons.
  • Following a worldwide prayer movement and significant political pressure from the United States government, Andrew was finally released in October 2018.
  • The eight-part series and study guide can be found here: frc.org/preparetostand
    View original content to download multimedia: https://www.prnewswire.com/news-releases/frcs-andrew-brunson-unveils-new...

Nutritional High to Be Renamed High Fusion; Provides Corporate Update on U.S. Cannabis Operations

Retrieved on: 
Thursday, September 9, 2021

"When I became CEO of Nutritional High in March 2020, the board and management team made a decision to establish a stable financial platform before expanding operations," stated Nutritional High CEO John Durfy.

Key Points: 
  • "When I became CEO of Nutritional High in March 2020, the board and management team made a decision to establish a stable financial platform before expanding operations," stated Nutritional High CEO John Durfy.
  • Nutritional High is preparing audited financial reporting for OutCo and, once complete, the company will report on all relevant metrics such as costs, net income and margins.
  • Nutritional high also expects to add a premium "High Fusion" line of organic edibles, full spectrum carts, and a unique Kosher gummy product.
  • Nutritional High has also appointed Simon Berdugo as Vice President of Manufacturing and Operations responsible for systemizing and centralizing operations with immediate focus on edibles.

In NCLA Amicus Win, Unanimous Supreme Court Protects Free Exercise of Religion for Foster Parents

Retrieved on: 
Thursday, June 17, 2021

As part of CSSs religious beliefs, it will not certify same-sex married couples as prospective foster families.

Key Points: 
  • As part of CSSs religious beliefs, it will not certify same-sex married couples as prospective foster families.
  • For this reason, in 2018, the City abruptly terminated foster placement through CSS.
  • The Citys decision left foster parents like Sharonell Fulton, who has fostered more than 40 children, without CSSs support.
  • Under Employment Division v. Smith, laws or regulations that incidentally burden free exercise may be upheld if they are neutral and generally applicable.

XPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Latest Progress Report on Mescaline Program for Psychedelic Therapies

Retrieved on: 
Tuesday, June 15, 2021

The audio press release covers XPhytos recent announcement regarding the status of its GMP mescaline synthesis program.

Key Points: 
  • The audio press release covers XPhytos recent announcement regarding the status of its GMP mescaline synthesis program.
  • To hear the audio production, visit: https://www.nnw.fm/GFUhh
    To read the original press release, visit: https://www.nnw.fm/dcaCA
    "With both its North American GMP mescaline synthesis program and German-based psilocybin biotechnology production underway, the first stage of XPhyto's psychedelic medicine program is progressing on schedule.
  • As the manufacturing programs advance, we look forward to focusing our expertise on psychedelic drug formulation," said Hugh Rogers, CEO & Director.
  • IBN is a comprehensive provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions.

DGAP-News: XPhyto Therapeutics Corp.: XPhyto Adds Mescaline Production to Psychedelic Medicine Programs

Retrieved on: 
Wednesday, February 10, 2021

VANCOUVER, BC / ACCESSWIRE / February 10, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to announce that XPhyto Laboratories Inc., its wholly owned Alberta subsidiary, has added mescaline production to its psychedelic medicine programs.

Key Points: 
  • VANCOUVER, BC / ACCESSWIRE / February 10, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to announce that XPhyto Laboratories Inc., its wholly owned Alberta subsidiary, has added mescaline production to its psychedelic medicine programs.
  • Mescaline has been anecdotally recognized as a relatively safe psychedelic drug and has shown particular promise for the treatment of addiction and depression.
  • "In addition to our European-based psilocybin biotechnology production, the Company has now expanded its portfolio of psychedelic compounds to include mescaline.
  • The Company believes that the industrial-scale production of pharmaceutical grade psilocybin and mescaline will provide a strong foundation for its psychedelic medicine programs.